 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Tirzepatide 2023788-19-2

Tirzepatide 2023788-19-2 buy - large image1

Tirzepatide 2023788-19-2

2102 Inquiries

Unit Price: Get Latest Price 

CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Packaging:

box

Sample Available:

Yes

Price valid (until):

2026-04-20

 The product will be displayed normally on the website later.

Hainan Fu Bai Trading Co., Ltd.

Company Type:

Trader

Location:

China

Average Lead Time:

10 days

Qualification:

Main Products:

Peptide products.

 Visit Store

Product Details
Seller Information
Inquiry History

Description

Product Detail

Pls input...

Items

Specifications

Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise

ECHEMI Editorial Reference

Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

Basic Info

Product Name:

Tirzepatide

Other Name:

LY3298176;

CAS No.:

2023788-19-2

Molecular Formula:

C225H348N48O68

Molecular Weight:

4813

EC Number:

200-001-8

Categories:

Bulk Drug Intermediates

Characteristics

Appearance:

White to off-white

Research

Class:

Dual agonist — GIPR, GLP-1R

Status:

FDA-approved (Mounjaro / Zepbound)

Mechanism:

Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

EC50 (Human GLP1R):

0.934 nM

EC50 (Human GIPR):

0.0224 nM

Source:

Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

Clinical Development:

NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503

FDA:

Mounjaro, Zepbound (approved 2022-05-13)

References

ChEMBL:

DrugBank:

KEGG DRUG:

PubChem:

Literature:

NEJM: Frias et al. (2021) — SURPASS-2; FDA: Mounjaro (NDA 215866)

Disclaimer:

Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

See More Tirzepatide Properties 

Seller Information

Business Type:
Trader

Main Products:
Peptide products.

Location:
No. 5, Guoxing Avenue, Lanshan District, Haikou City, Hainan Province. 2nd floor, Hainan Building. No. 206-102, Meilan District Digital Economy Park.

Average lead Time:
10 days

Total Annual Revenue:
Less than $1 million

Total Employees:
11-50

Year of Establishment:
2025

Inquiry History

2102 Inquiries

Country	Product	Purchase Quantity	Date Posted
Belgium	Tirzepatide	10 MG	Oct 28, 2026
United States	tirzepatide	100 MG	Oct 28, 2026
United States	Tirzepatide	60 MG	Oct 28, 2026
United States	Tirzepatide	10 PCS	Oct 28, 2026
United States	tirzepatide	30 MG	Oct 27, 2026
United States	Tirzepatide	40 MG	Oct 27, 2026
Philippines	Tirzepatide	2 MT	Oct 27, 2026
Philippines	Tirzepatide	30 MG	Oct 26, 2026
Slovakia	Tirzepatide	1 G	Oct 26, 2026
France	Tirzepatide	1 KG	Oct 25, 2026
United States	Tirzepatide	2.5 MG	Oct 25, 2026
United Kingdom	Tirzepatide	5 MT	Oct 25, 2026
United Kingdom	Tirzepatide	6 MT	Oct 24, 2026
Peru	tirzepatide	10 MG	Oct 21, 2026
Puerto Rico	tirzepatide	40 MG	Oct 21, 2026
United States	Tirzepatide	10 MT	Oct 21, 2026
South Africa	Tirzepatide	1 MT	Oct 20, 2026
United States	Tirzepatide	5 KG	Oct 20, 2026
United States	tirzepatide	30 MG	Oct 20, 2026
United States	Tirzepatide	50 MG	Oct 20, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
BB10\| BPC5mg+TB5mg \| Factory Price \| Cosmetic Peptides \| 99% Purity \|Lyophilized Powder	Industrial Grade/99	$28-30/UNIT FOB	Tianjin Hengyuanxing Trading Co., Ltd.	Inquiry
Tirzepatide Research Peptide Lyophilized Powder 99% Purity For Research Use Only	Research Grade/99.9	$20-25/G FOB	Tianjin Huifeng Technology Co., Ltd.	Inquiry
Semaglutide \| Weight Loss Peptides \| 99% Purity \|5mg 10mg 15mg Vials \| Fast Shipping In Stock	Pharmaceutical Grade/99	$25/UNIT FOB	Dalian Honglu Chemical Co., Ltd.	Inquiry
High Quality 99% Purity Tirzepatide Weight Loss Peptide Lyophilized Powder hot sale CAS 2023788-19-2	Pharmaceutical Grade/99.9	$1/UNIT EXW	NATURE INDUSTRIAL LIMITED	Inquiry
Top Quality Peptides Lyophilized Powder Tirzepatide Fitness and Weight Loss	Pharmaceutical Grade/99	$20-25/G FOB	Tianjin Apex Import and Export Trading Co., Ltd.	Inquiry

Tirzepatide 2023788-19-2

Product Details

Seller Information

Inquiry History

More Choices Find All Products for Sale 

Related Searches

More from this Seller